Being a CF brother and scientist has been a journey... not a fair one in many ways, but I always have this quote in mind:
"It is not how much we do, but how much love we put in the doing..." 💜

#cysticfibrosis #CFAwarenessMonth #addingtomorrows #justbreathe #CFwarrior #dumspirospero

Team Doodle is checked in and ready to walk for Alphy who is at home recovering from their lung transplant. #cf #cysticfibrosis #addingtomorrows

What an achievement!! 🏆✨🎉🧑🏻‍🔬

Thank you @ScholarGPS

#cysticfibrosis #addingtomorrows #precisionmedicine #scientist #scholargps

@emory-choa-cfair.bsky.social

scholargps.com/scholars/293...

8 years and counting... It feels like "a life" has passed since then! 👨‍🔬🥼🧬🧫🔬💊🫁

🎼This is the beginning of the rest of your life 🎶
🎼Chasing a dream so real 🎶

#phdjourney #8yearsago #oldbutgold #cysticfibrosis #addingtomorrows #fight4cure

Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor The monogenic rare disease Cystic Fibrosis (CF) is caused by mutations in the gene encoding the CF transmembrane conductance (CFTR) protein, an anion channel expressed at the apical plasma membrane of...

Our new paper has been published: "Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor" in Molecules MDPI 🧑‍🔬🔬🧫🧬💊

#cysticfibrosis #personalizedmedicine #cftrmodulators #addingtomorrows

www.mdpi.com/1420-3049/29...

Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in ... The implementation of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulator drugs into clinical practice has been attaining remarkable therapeutic outcomes for CF, a life-threateni...

Our new paper has been published: "Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis" in @JPM_MDPI 🧑‍🔬🔬🧫🧬💊 #cysticfibrosis #personalizedmedicine #cftrmodulators #invitromodels #addingtomorrows

www.mdpi.com/2075-4426/14...